Dearborn Partners LLC Eli Lilly & CO Transaction History

Dearborn Partners LLC

$2.42 Billion
Q3 2024

A detailed history of Dearborn Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dearborn Partners LLC holds 4,703 shares of LLY stock, worth $3.52 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,703

Previous 4,648 1.18%

Holding current value

$3.52 Million

Previous $4.21 Million 1.0%

% of portfolio

0.17%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $42,467 - $52,801	55 Added 1.18%	4,703 $4.17 Million
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $26,820 - $33,634	37 Added 0.8%	4,648 $4.21 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $39,085 - $52,290	-66 Reduced 1.41%	4,611 $3.59 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $68,799 - $81,106	131 Added 2.88%	4,677 $2.73 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $58,249 - $80,306	-134 Reduced 2.86%	4,546 $2.44 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $15,783 - $21,104	45 Added 0.97%	4,680 $2.19 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $17,084 - $20,065	55 Added 1.2%	4,635 $1.59 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $41,158 - $47,957	-128 Reduced 2.72%	4,580 $1.68 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $37,949 - $43,247	128 Added 2.79%	4,708 $1.52 Million
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $27,873 - $32,727	100 Added 2.23%	4,580 $1.49 Million
Q1 2022 May 04, 2022	SELL	$234.69 - $291.66 $3,285 - $4,083	-14 Reduced 0.31%	4,480 $1.28 Million
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $1,329 - $1,636	6 Added 0.13%	4,494 $1.04 Million
Q1 2021 Apr 29, 2021	BUY	$164.32 - $212.72 $22,183 - $28,717	135 Added 3.1%	4,488 $838,000
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $68,491 - $90,630	525 Added 13.71%	4,353 $735,000
Q3 2020 Oct 20, 2020	SELL	$146.22 - $169.13 $51,030 - $59,026	-349 Reduced 8.36%	3,828 $567,000
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $3,274 - $3,940	24 Added 0.58%	4,177 $686,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $79,406 - $98,282	667 Added 19.13%	4,153 $576,000
Q3 2019 Oct 29, 2019	SELL	$106.79 - $116.16 $2,883 - $3,136	-27 Reduced 0.77%	3,486 $390,000
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $29,802 - $34,787	-269 Reduced 7.11%	3,513 $389,000
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $635 - $711	-6 Reduced 0.16%	3,782 $438,000
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $76,243 - $95,291	888 Added 30.62%	3,788 $406,000
Q1 2018 May 01, 2018	SELL	$74.21 - $87.6 $27,457 - $32,411	-370 Reduced 11.31%	2,900 $224,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,270	3,270 $269,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account

Dearborn Partners LLC Eli Lilly & CO Transaction History